Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Aster Wakjira Garedow has a total of 55 co-authors. Here are the top co-authors by number of shared publications:

  • Gorfineh Teshome Tesfaye

    Jimma University Medical Center, Jimma, Ethiopia

    5 shared publications
  • Amare Desalegn Wolide

    Facility of Medicine, Jimma University, 378, Jimma, Ethiopia

    3 shared publications
  • Eshetu Mulisa Bobasa

    Faculty of Health Sciences, School of Pharmacy, Jimma University, 378, Jimma, Ethiopia

    3 shared publications
  • Evelien Wynendaele

    Translational Research in Immunosenescence, Gerontology and Geriatrics (TRIGG) group Ghent University Hospital Ghent Belgium

    3 shared publications
  • Addisalem Gebresilase Hailemariam

    Jimma University, School of Medicine, Jimma, Ethiopia

    2 shared publications
  • Bart De Spiegeleer

    Translational Research in Immunosenescence, Gerontology and Geriatrics (TRIGG) group Ghent University Hospital Ghent Belgium

    2 shared publications

Latest Publications

  • Open Access

    Virologic and Immunological Failure and Associated Factors Among Adults Living With HIV on HAART at Jimma Medical Center, Southwest Ethiopia

    by Rahel Tamrat Teshome, Mulatu Gashaw, Aster Wakjira Garedo, Tesfaye Deme, Wondimagegn Adissu, Daniel Yilma, Zeleke Mekonnen, Lealem Gedefaw Bimerew

    Background: Antiretroviral therapy reduces HIV morbidity, mortality, viral replication, and transmission, and viral load testing is the preferred method for monitoring effectiveness. This study assessed virologic and immunologic failure and associated factors among adults living with HIV on HAART at Jimma Medical Center, southwest Ethiopia. Methods: An institution-based cross-sectional study was conducted from February to March 2019 among 272 adults on HAART. Data were collected from medical records and structured interviews. CD4+ T-cell counts and plasma viral loads were measured using standard laboratory procedures. Data were analyzed using SPSS version 24. Descriptive statistics summarized the data, and bivariate and multivariate logistic regression analyses were performed to identify associated factors. Multicollinearity was assessed before the final model. Adjusted odds ratios (AORs) with 95% confidence intervals were reported, and a P -value <.05 was considered statistically significant. Results: Of the participants, 60.7% were female, with a mean age of 36.6 years and a median ART duration of 96 months. Immunologic failure occurred in 8.1% and virologic failure in 10.3%. Immunologic failure was associated with tuberculosis co-infection and poor ART adherence. Virologic failure was associated with poor adherence, baseline viral load ≥1000 copies/mL, and CD4+ count 3 . Conclusion: Adherence support remains essential for viral suppression.

  • Open Access

    Role of Peptides in Skeletal Muscle Wasting: A Scoping Review

    by Petar Naumovski, Bart De Spiegeleer, Aster Wakjira, Christophe Van De Wiele, Vincent Mouly, Katarzyna Goljanek‐Whysall, Kauê Santana da Costa, Ewerton Cristhian Lima de Oliveira, Evelien Wynendaele, Anton De Spiegeleer

    Background: Systemic muscle wasting is a prevalent condition that predicts adverse health outcomes in aging and disease. Despite its clinical relevance, the development of predictive biomarkers and effective pharmacological therapies remains limited. Peptides have recently gained attention for their diverse bioactive functions, positioning them as promising biomarkers and therapeutic agents for muscle wasting. Methods: This scoping review systematically identifies studies examining the direct association between well‐defined peptides and clinical components of muscle wasting: muscle mass, strength and physical performance. The review follows the Preferred Reporting Items for Systematic Reviews and Meta‐Analysis for Scoping Reviews (PRISMA‐ScR) guidelines. A comprehensive search of Embase, PubMed and Web of Science was conducted up to 31 October 2024, focusing on original human or animal studies. Studies involving congenital or inherited muscle disorders, inflammatory myopathies and neurodegenerative diseases, such as Parkinson's disease, were excluded. A snowball approach was used to synthesize the presumed cellular pathways of identified peptides. Results: A total of 126 studies were included: 71 (56.3%) focused on a single muscle wasting component (48 on mass, 16 on strength and 7 on performance), 31 (24.6%) examined two, 16 (12.7%) analysed all three separately, and 8 (6.3%) assessed sarcopenia as a categorical variable. Eighty‐seven distinct peptides linked to muscle wasting were identified, ranging from collagen tripeptide (3 amino acids) to insulin (51 amino acids). The most studied peptides are ghrelin (14.3%), brain natriuretic peptide (BNP, 11.1%), C‐peptide (11.1%), insulin (10.3%) and Szeto‐Schiller 31 (SS‐31, 6.3%). Most (62.1%) influence one or more of four key muscle homeostasis pathways (PI3K/Akt/mTOR, ActR/SMAD, IKK/NF‐κB and AMPK/PGC1α), which regulate atrophy (via FOXO, NF‐κB, SMAD2/3, glucocorticoid receptor and GSK‐3β) and hypertrophy (via androgen receptors, PGC‐1α and S6K). Flaws in study design and reporting were prevalent, hindering clinical translation. Sex bias was evident, with females comprising 23.9% of participants in human interventional studies and only 9.1% and 12.4% of mice and rats in rodent studies, respectively. Clinical, pre‐analytical and analytical reporting gaps were common: 56.6% documented diurnal timing, food intake and activity around peptide collection; none specified storage‐to‐analysis duration; and only 11.5% reported detection limits for peptide measurements. Conclusion: This scoping review highlights the potential of peptides as biomarkers and intervention targets for muscle wasting. It connects the cellular receptors and signaling pathways linking peptides with skeletal muscle wasting. Improving clinical translation requires addressing study design limitations, incorporating more representative study populations and adhering to standardized reporting guidelines. The application of machine learning can support the identification of novel bioactive peptides.


  • Open Access

    Chemotherapy-related adverse drug reaction and associated factors among adult cancer patient attending Jimma medical center oncology unit, Southwest Ethiopia

    by Mukerem Sultan Shrmeka, Mubarik Fetu Semman, Biruk Tafese Moges, Feki Nekir Dereja, Aster Wakjira Garedo

    Background: In 2017, reports of adverse drug reactions worldwide reached an estimated 35 million.Chemotherapeutic agents were one of the most often implicated pharmacological classes in inducing adverse drug reactions. Adverse drug reactions increase the overall expense and mortality. Adverse drug reactions increase morbidity, mortality, hospitalization rate and financial expenses. Therefore, this study intended to assess chemotherapy-related adverse drug reactions and associated factors among adult cancer patients. Patients and method: A facility-based prospective observational study was conducted from July 2022 to October 2022 at Jimma Medical Center’s oncology unit. A standard data collection tool (Naranjo’s algorithm, modified Hartwig’s severity scale, and modified Schumock-Thornton criteria) was used for assessment of causality, severity, and preventability of adverse reactions, respectively. Socio-demographic profile and any adverse drug reactions reported were collected separately. The data was collected by one pharmacist and two nurses after giving training. Data was entered into Epidata version 4.6.0 and analyzed by SPSS version 25. Bivariate and multivariable logistic regression was conducted to identify independent predictors of the pattern of adverse drug reaction occurrence. A P-value of 0.05 was taken as statistically significant. Result: Out of 154 patients enrolled in the study, 66.2% were female. The mean age of patients was 41.20 ± 13.54 years. From the total, 98 (63.6%) cases developed a total of 198 adverse drug reactions. Out of them, 59.2% were female. The most commonly encountered adverse drug reactions were nausea and vomiting (33.8%) and hair loss (29.3%). Most of the reactions were probable (61.1%) in causality, mild (66.2%) in severity, and not preventable (43.9%) in nature. Female sex (AOR = 1.054; 95% CI= (1.021–1.087); P = 0.001), number of chemotherapy treatments (AOR = 3.33; 95% CI= (1.301–8.52); P = 0.012), and elderly age (AOR = 3.065; 95% CI= (1.01–9.296); P = 0.048) were associated with occurrences of adverse drug reactions. Conclusion: We can deduce from the data that adverse drug reactions are a significant concern for patients undergoing chemotherapy, with nearly two-thirds experiencing ADRs. The most common reactions are nausea and vomiting, which are mostly mild and probable. Age, gender, and the use of several chemotherapy drugs were associated with an increased risk of adverse drug reactions. Hence all concerned bodies should make an effort for early detection and take preventive measure of chemotherapy-related adverse drug reactions. Where feasible, use chemotherapy protocols with alower risk of ADRs. Evaluate dose adjustments for elderly patients. Implement protocols for risk assessment before initiating chemotherapy.


  • Open Access

    The association between statins and gait speed reserve in older adults: effects of concomitant medication

    by Anton De Spiegeleer, Antoon Bronselaer, Ine Mahieu, Dorien Vreys, Aaron Haslbauer, Jan-Philipp Leibfarth, Lara Van Schoote, Aster Wakjira, Mirko Petrovic, Evelien Wynendaele, et al.

    Statins are frequently prescribed to older adults, yet their effects on ageing phenotypes such as frailty or physiological reserves remain poorly understood. Gait Speed Reserve (GSR), defined as the difference between maximal and usual gait speeds, serves as an indicator of physiological reserve, reflecting the body’s ability to perform beyond baseline functional levels. Polypharmacy, prevalent in this population, may contribute to inconsistent findings through interactions between statins and concomitant medications. We aimed to investigate how concomitant medications moderate the association between statin use and GSR in older adults. To this end, we conducted a cross-sectional observational cohort study using data from the Mobility Center at the University Department of Geriatric Medicine FELIX PLATTER, Basel, Switzerland ( n = 5519 adults aged ≥ 60 years). Moderation regression analyses with propensity score weighting were used to evaluate the effect of concomitant medications on the association between statin use and GSR. Results showed statin use was associated with a lower GSR compared to non-use (− 1.9 cm/s [95% CI, − 3.1 to − 0.72]). However, ACE inhibitors and aspirin significantly influenced this association. The GSR difference for statin users compared to non-users increased by 3.7 cm/s (from − 2.2 to 1.5 cm/s; 95% CI, 0.0 to 7.4) with concomitant ACE inhibitor use and by 5.8 cm/s (from − 3.4 to 2.3 cm/s; 95% CI, 2.5 to 9.1) with aspirin use. We found no statistically significant association between statin use and usual gait speed, the secondary outcome. In conclusion, ACE inhibitors and aspirin interacted with statins, reversing the negative association with GSR into a positive one when co-used. Future clinical trials are needed to determine causality and further investigate the impact of concomitant medication use on statin effects in aging populations. Meanwhile, our findings underscore the importance of considering concomitant medication use when assessing the effects of statins in older adults.


  • Open Access

    Bacterial profile, treatment outcomes, and determinants among adult patients with musculoskeletal infections admitted to Jimma Medical Center: A prospective observational study

    by Desalegn Gizaw, Gorfineh Teshome, Kisi Chemeda, Aster Wakjira, Mekonnen Damessa

    Background: The epidemiological characteristics of musculoskeletal infections are constantly evolving. Despite the significant burden of musculoskeletal infections in sub-Saharan Africa, there is a scarcity of data regarding the potential causes and treatment outcomes of such infections in the region. Therefore, the primary objective of this study was to assess a management protocol, clinical outcomes, and associated factors among adult individuals diagnosed with musculoskeletal infections. Methods: Adult patients admitted to Jimma University Medical Center (JUMC), Ethiopia with a diagnosis of musculoskeletal infections was enrolled prospectively from July 2022-December 2022. Clinical characteristics, management protocol, and complications were recorded from admission to discharge. Bacteria were identified by a series of biochemical tests, and antimicrobial susceptibility testing was performed using the Kirby-Bauer Disk diffusion method. Data were analyzed by using SPSS v.23 and the p-value The common bacterial isolates were Staphylococcus aureus in (22.4%), Escherichia coli (18.1%), Pseudomonas aeruginosa (14.7) and Klebsiella pneumonia (11.2). The isolated etiologies were resistant to Ceftriaxone in 67(81.70%) and Ceftazidime in 47(61.8%) of test results. Nearly all (98.8%) of patients were took antibiotics on admission and Ceftriaxone was highly utilized as monotherapy in (23.4%) of patients. Nearly half (46.9%) of the patients were develop treatment failure. Sex [AOR = 2.56, 95%CI (1.07–6.23)], microbial growth [AOR = 3.03, 95%CI (1.31–6.97)], ceftriaxone resistance [AOR = 4.46, 95%CI (1.06–18.67)], co-morbidities [AOR = 2.32, 95%CI (1.007–5.36)], and complications [AOR = 2.80, 95%CI (1.26–6.20)] were associated with treatment failure outcome. Conclusion: Close to half of adult patients with musculoskeletal infections experienced treatment failure. Staphylococcus aureus stood out as the prevailing bacterial strain identified. The timely switching of parenteral antibiotics to oral counterparts, alongside timely surgical interventions, significantly enhanced the recovery outcomes for these individuals.


  • Open Access

    Glycemic control and associated factors in patients with type 2 diabetes in Southwest Ethiopia: a prospective observational study

    by Aster Wakjira Garedo, Gorfineh Teshome Tesfaye, Rahel Tamrat, Evelien Wynendaele

    Background: Diabetes, a known syndrome marked by hyperglycemia and glucose intolerance, is increasing at an alarming rate worldwide. Over half a billion people worldwide have DM, and most live in low- and middle-income countries. Poor glycemic control is a public health concern in type 2 diabetes mellitus. Glycemic control and identifying factors associated with poor glycemic control can help healthcare providers design programs that improve glycemic control and the quality of services provided to patients. Objectives: This study was designed to assess the level of glycemic control and associated factors in patients with type 2 diabetes in Jimma Medical Center, Southwest Ethiopia. Methods: This institution-based prospective observational study was conducted among 420 patients with type 2 diabetes at Jimma Medical Center’s diabetic clinics. A pretested structured interviewer-administered questionnaire was used to collect data, and a checklist was used to assess patient documents. The data were analyzed using SPSS version 26. The variables linked to poor glycemic control were investigated using binary logistic regression. Variables with p values less than 0.05 were considered statistically significant. Results: Six-month follow-ups were conducted among 420 patients with type 2 diabetes, among whom 220 (52.38%) were women. The median age of the participants was 54(IQR = 40–60 years old). The proportion of respondents with uncontrolled fasting blood glucose was 58.1%. Sex (AOR = 2.576, 95% CI [2.80-11.479], P = 0.001), age(≥ 60) (AOR = 2.024, 95% CI [1.794–4.646], P = 0.002), diabetes duration > 10 years (AOR = 3.036, 95% CI [2.616–8.306], P = 0.003), type 2 diabetes mellitus on insulin + oral antidiabetic (OADs) (AOR = 2.08, 95% CI [298-3.918], P = 0.004), obesity (AOR = 2.18, 95% CI [(1.218–4.218)], P = 0.003), diabetic complications (AOR = 3.193, 95% CI [2.324–6.05], p = 0.002) and poor self-care practices (AOR = 3.034, 95% CI [5.821–7.02], P = 0.005) were found to be significantly associated with poor glycemic control. Conclusion: At the Jimma Medical Center, the prevalence of poor glycemic control was high. Based on these findings, teaching and counseling provided by healthcare providers should focus on improving diabetes self-care activities, weight reduction, and diabetic complications to achieve good glycemic control. Clinical trial number: Not applicable.


  • Open Access

    Faecal carriage of extended-spectrum beta-lactamase and carbapenemase-producing enterobacterales among HIV patients at Jimma Medical Center, Southwest Ethiopia

    by Dechasa Befikadu, Rahel Tamrat, Aster Wakjira Garedo, Getenet Beyene, Esayas Kebede Gudina, Mulatu Gashaw

    Enterobacterales infections in immunocompromised individuals are associated with considerable morbidity, mortality, and health care costs. This study aimed to assess the faecal carriage of extended-spectrum β-lactamase (ESBL) and carbapenemase-producing Enterobacterales (CPE) among HIV-infected patients at Jimma Medical Center. A total of 344 stool samples were collected and inoculated on Mac-Conkey and Eosin-Methylene Blue agar and incubated at 35–37 °C aerobically. ESBL and carbapenemase production were detected using D68C ESBL/AmpC and D73C CARBA plus (Mast Group, UK). A total of 376 Enterobacterales were isolated. The prevalence of ESBL-PE and CPE carriage rate was 13.3% (50/376) and 4.3% (16/376) respectively. The highest proportion of ESBL producing isolates were found in K. pneumoniae 29.0% (9/31) followed by E. coli 13.4% (39/292). Similarly, K. pneumoniae 12.9% (4/31) was the most common carbapenem-resistant isolate followed by E. coli 3.8% (11/292). Multi-drug resistance was observed in 66.5% (250/376) of the isolates. Prior cephalosporin use (AOR = 7.9; 2.31–27.29), CD4 count (≤ 350 cells/µL) (AOR = 3.8; 1.12–12.9), and comorbidities (AOR = 2.3; 1.24–4.32) were significantly associated with ESBL production. Additionally, cephalosporin use (AOR = 6.34; 1.27–31.66) was significantly associated with the presence of CRE. This study revealed a high prevalence of ESBL-PE and CPE among HIV patients, with K. pneumoniae and E. coli being the dominant isolates. MDR was common, with key risk factors being prior cephalosporin use, low CD4 counts, and comorbidities. These findings emphasize the need for enhanced infection prevention and control, regular screening, and improved antibiotic stewardship to curb the spread of resistant bacteria in immunocompromised individuals.


  • Open Access

    Medication Related-Problems and Associated Factors Among Patients with Hypertension at a Tertiary Care Hospital in Ethiopia: A Prospective Interventional Study

    by Aster Wakjira Garedow, Mekonnen Damessa Mamo, Gorfineh Teshome Tesfaye

    Background: Hypertension affects more than 1.4 billion people worldwide currently, with that number anticipated to climb to 1.6 billion by 2025 with high mortality and morbidity effects. Medication related problems in cardiovascular disease patients, especially among hypertension patients were found to be high and a critical problem which is associated with high mortality, complication, prolonged hospital stay, compromised quality of life and increase health care cost. Objective: To determine medication related problems and its predictors among hypertension patients on chronic follow-up at Jimma Medical Center. Methods: A prospective interventional study was conducted among hypertension patients from November 28, 2021 to June 30, 2022 at Jimma Medical Center. Medication related problems were classified and identified based on Pharmaceutical care network Europe drug classification tool version 9.0. Interventions were done through discussion with individual prescriber and patients. Consecutive sampling technique was used. Binary Logistic regression was used to identify independent predictors of medication related problems. Variables having P-values < 0.05 were considered statistically significant. Results: Among 384 hypertension patients included in the study, 219 (57.1%) were male. The mean (SD) age was 49.06+17.79. Two thirds of study participants had at least one medication related problem. A total of 483 MRPs were identified among 231 (60.15%) patients. Treatment effectiveness related problem (55.48%) was the most common observed medication related problems. Alcoholism (AOR; 3.15, 95% CI [1.46– 7.23]), stage II hypertension (AOR=2.77, 95% CI= [3.53– 4.66]); comorbidity (AOR=2.88, 95% CI= [1.47– 5.66]) and polypharmacy (AOR=3.07, 95% CI= [1.57– 5.99]) were the independent predictors of medication related problems. Conclusion: The prevalence of medication related problems was high among hypertensive patients. Alcoholism, stage II hypertension, comorbidity and poly-pharmacy were the predictors of medication related problems. Therefore, to overcome the problems, clinical pharmacists, physicians and other health care professionals have to work in collaboration.


  • Open Access

    Lifestyle modification and medication use among diabetes mellitus patients attending Jimma University Medical Center, Jimma zone, south west Ethiopia

    by Aster Wakjira Garedow, Tsiyon Mekoya Jemaneh, Addisalem Gebresilase Hailemariam, Gorfineh Teshome Tesfaye

    Diabetes, a non-communicable metabolic disease, causes multiple complications and deaths worldwide. It is a complex, chronic disease that requires continuous medical care with multifactorial risk reduction strategies beyond glycemic control. Ongoing patient education and self-management support are critical for preventing acute complications and reducing the risk of long-term complications. There is ample evidence that healthy lifestyle choices, such as a healthy diet, moderate weight loss, and regular exercise, can maintain normal blood sugar levels and minimize diabetes-related complications. In addition, this lifestyle change has a major impact on controlling hyperglycemia and can help to maintain normal blood sugar levels. This study aimed to assess lifestyle modification and medication use in patients with diabetes mellitus at Jimma University Medical Center. Hospital-based prospective cross-sectional study was conducted from April 1 to September 30, 2021 among DM patients who have follow-up at diabetic clinic of Jimma University Medical Center. Consecutive sampling was used until the required sample size was achieved. Data were checked for completeness, then entered into Epidata version 4.2 software and exported to SPSS version 21.0. Pearson’s chi-square test was performed to determine the association between KAP and independent factors. Variables with a p value < 0.05 were considered significant. A total of 190 participants took part in this study with a response rate of 100%. In this study, 69 (36.3%) participants had good knowledge, 82 (43.2%) moderate knowledge and 39 (20.5%) poor knowledge, 153 (85.8%) had positive attitudes, 141 (74.2%) had good practice. Marital status, Occupational status and educational status were significantly associated with knowledge and attitude towards LSM and medication use. Marital status was the only variable that remained significantly associated with knowledge, attitude and practice towards LSM and medication use. The result of this study showed that more than 20% of the participants had poor knowledge, attitude, and practice towards medication use and LSM. Marital status was the only variable which remained to be significantly associated with KAP towards LSM and medication use.


  • Open Access

    Medication Related Problems and its predictors among heart failure patients at a tertiary care hospital in Ethiopia: A prospective interventional study

    by Aster Wakjira Garedow, GorfinehTeshome Tesfaye

    Background Medication related problems in cardiovascular disease patients, especially among heart failure patients were found to be high. Medication related problem is a critical problem to provide high quality health care service for the patient which is associated with high mortality, complication, prolonged hospital stay, compromised quality of life and increase health care cost. Objective To determine medication related problems and its predictors in hospitalized heart failure patients at Jimma Medical Center, from May 30, 2019 to November 28, 2020 Methods A prospective interventional study was conducted among heart failure patients from May 30, 2019 to November 28, 2020 at Jimma Medical Center. Medication related problems were sorted based on Pharmaceutical care network Europe drug classification tool version 9.0. Patient’s specific data was collected using questionnaire. The data were coded, cleaned, and entered into Epidata version 4.6 and exported to SPSS version 25.0 for analysis .Binary Logistic regression was used to identify independent predictors of medication related problems occurrence. Variables having P-values < 0.05 were considered statistically significant Results A total of 384 heart failure patients were included in the study. The mean (SD) age was 49.06 ± 17.79. Two third of study participants had at least one medication related problem. A total of 483 MRPs were identified among 231(60.15%) patients. Treatment effectiveness related problem (55.48%) was the most common observed medication related problems. Alcoholism (AOR; 3.25, 95% CI (1.46–7.23), prolonged hospital stay [AOR = 3.67, 95%CI= (1.85–7.27)]; comorbidity [AOR = 2.88, 95%CI= (1.47–5.66)] and polypharmacy [AOR = 3.07, 95%CI= (1.57–5.99) were the independent predictors of medication related problems. Conclusion The prevalence of medication related problem was high among heart failure patients. Alcoholism, prolonged hospital stay, comorbidity and polypharmacy were the predictors of medication related problems. Hence, to overcome these problems, clinical pharmacists, physicians and other health care professionals have to work in collaboration.